|
|
|
||||
|
|
|||||
|
Computerized results of Menopause Type® Questionnaire: |
|||||
|
Menopause Type® Three |
See Pages
96-101 |
||||
|
Menopause Type® Three has symptoms that suggest adequate estradiol and adequate progesterone function, but excessive testosterone function. |
|||||
|
Health risks associated with Menopause Type® Three
may include blood sugar (diabetes) and insulin problems (insulin resistance),
increased risk of endometrial cancer and heart disease. By managing your menopause type® you
will improve your quality of life. & decrease your risks of disease. |
|||||
|
PROTOCOL: The following protocol provides women with
Menopause Type® 3 information on which nutritional and herbal
formulations can support the normal function of hormone responsive tissues.
Please review the Advanced
Integrative Management of Menopause document for more
detailed information. |
|||||
|
Foundational Interventions: |
|||||
|
Foundational
interventions include lifestyle and
dietary choices that support optimal hormone function. In addition, a
high grade multiple vitamin mineral formulation rich in antioxidants and
essential fatty acids rich in docosahexaenoic
acid are required for optimal hormone function. |
|||||
|
Ultra Preventive® X V-Cap - A high grade multiple vitamin and mineral
supplement with significant antioxidant support. Vitamins and minerals are cofactors required for every
biochemical process in the human body, including the production and proper
detoxification of hormones. Oxygen stress contributes to some of the
pathophysiolgical effects of suboptimal menopause. These effects may be
prevented and/or treated by improving the antioxidant defense of
perimenopause, menopause, and postmenopausal women. |
|||||
|
Opti DHA - An essential fatty acid
rich in docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), with a
high DHA:EPA ratio. The essential fatty acid DHA help maintain ideal cell membrane
fluidity allowing optimal transport of molecules across the membrane, which
is critical for hormone function, while EPA helps the body control
inflammation. |
|||||
|
Primary Endocrine Formulations : |
|||||
|
Primary
Endocrine Nutraceutical formulations should be used to support the function of
hormone producing glands and hormone responsive tissues. The primary formulation that is
appropriate to manage hormonal imbalances observed in Menopause Type® Three is: |
|||||
|
Testo-Quench™, a synergistic formulation of phytoantiandrogens designed to restore healthy hormone balance by calming and supporting the ideal
function of testosterone sensitive tissues as needed in Menopause Type®
Three. More Information on Testo-Quench™ |
|||||
|
Please Find a Healthcare Professional in your area to customize these
protocols. |
|||||
|
Secondary Endocrine Formulations: |
|||||
|
Since decreased thyroid function can adversely
affect the function of other hormones, a nutraceutical formulation to support the function of the thyroid gland
and the liver (which converts T4 to T3) and also
supports the function and response of tissues that respond to thyroid
hormones should be used if there are signs
and symptoms of decreased thyroid function. As noted, there may be decreased blood glucose function in Menopause Type® Three due to the primary hormone imbalances. Excessive body weight also increases the risk for decreased blood glucose function. A nutraceutical formulation to support healthy blood glucose function should be used if there are signs and symptoms of decreased blood sugar function |
|||||
|
Thyro-Mend™ is a synergistic combination of iodine containing seaweeds, and herbs
which contain phytothyroidogenic, phyto-thyroid-receptor agonists, and other
herbs designed to promote optimal function of thyroid hormones by maintaining
the health of thyroid hormone producing tissues and by supporting the healthy
function of tissues that respond to thyroid hormones. More information on Thyro-Mend™ |
|||||
|
Glucobrium
is a synergistic formulation of phytotherapeutic extracts which mimic and
potentiate the actions of insulin and support healthy blood glucose function.
More information on Glucobrium. |
|||||
|
When to Consider
Hormone Precursors & Bioidentical Hormone Replacement Therapy |
|||||
|
If indicated, a hormone precursor such as Pregnenolone 25 Mg Tab may be used to support
hormone production pathways that create progesterone. It has mild hormone
actions, and does not have the same risks that are associated with Hormone
Replacement Therapies (HRT). Bioidentical Hormone
Replacement Therapy (BHRT), while considered more appropriate than synthetic
hormone therapies, does not support the hormone production pathways, but instead
provides “replacement”, which may further diminish endogenous hormone
production. Evaluation of hormone
levels, use of hormone precursors as needed, and as a final course of action, the prescription of bioidentical
hormone therapies should be considered only when restoration of normal
function is not possible. |
|||||
|
Also Review: |
|||||
|
Make the Right Choice |
|||||
|
Work with a Healthcare Professional
in your area: Find a healthcare professional in your area who has shown
such commitment as to take an extensive course of study on Menopause Type®
management, including nutritional, herbal & natural hormone therapies. Please go to Find a
Healthcare Professional . |
|||||
|
How Your
Menopause Type® Was Calculated
(www.YourMenopauseType.com/Questionnaire.html#Calculate) |
|||||
|
|
|||||
|
♦These statements have not been evaluated by the
Food and Drug Administration. |
|||||
|
Review Disclaimer & Legal
(www.YourMenopauseType.com/Disclaimer) |
|||||
YourMenopauseType.com,
Inc.
|
|||||
|
Last update
031817 |
|||||
|
|
|||||